Lentiviral shRNA mediated knockdown of FAP reduced cell proliferation, together with induction of cell cycle arrest of cancer cells in a xenograft mouse model of oral squamous cell carcinoma (OSCC), underlining the relevance of FAP-CCL2-signaling as therapeutic target in solid tumors [93]. This evidence concerns the gene CCL2 and cancer.